Nanoporous Gold Monolith for High Loading of Unmodified Doxorubicin and Sustained Co-Release of Doxorubicin-Rapamycin

Nanoparticles (NPs) have been widely explored for delivering doxorubicin (DOX), an anticancer drug, to minimize cardiotoxicity. However, their efficiency is marred by a necessity to chemically modify DOX, NPs, or both and low deposition of the administered NPs on tumors. Therefore, alternative strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattarai, Jay K., Neupane, Dharmendra, Nepal, Bishal, Demchenko, Alexei V., Stine, Keith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830488/
https://www.ncbi.nlm.nih.gov/pubmed/33467416
http://dx.doi.org/10.3390/nano11010208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830488/
https://www.ncbi.nlm.nih.gov/pubmed/33467416
http://dx.doi.org/10.3390/nano11010208

Ejemplares similares